Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
KLF5 encodes a member of the Kruppel-like factor subfamily of zinc finger proteins. Additionally we are shipping KLF5 Kits (5) and KLF5 Proteins (3) and many more products for this protein.
Showing 10 out of 64 products:
Human Polyclonal KLF5 Primary Antibody for EIA, WB - ABIN453149
Guo, Dong, Zhang, Zhao, Sun, Li, Dong: Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. in The Journal of biological chemistry 2009
Show all 5 references for ABIN453149
Human Polyclonal KLF5 Primary Antibody for FACS, IF - ABIN391515
Delgado-Olguín, Dang, He, Thomas, Chi, Sukonnik, Khyzha, Dobenecker, Fish, Bruneau: Ezh2-mediated repression of a transcriptional pathway upstream of Mmp9 maintains integrity of the developing vasculature. in Development (Cambridge, England) 2014
Show all 2 references for ABIN391515
Human Polyclonal KLF5 Primary Antibody for ICC, IF - ABIN4329154
Chen, Lin, Tang: Matrix-Stiffness-Regulated Inverse Expression of Krüppel-Like Factor 5 and Krüppel-Like Factor 4 in the Pathogenesis of Renal Fibrosis. in The American journal of pathology 2015
Human Polyclonal KLF5 Primary Antibody for IF (p), IHC (p) - ABIN739515
Zhang, Ha, Larouche, Swanson, Goldowitz: Kruppel-Like Factor 4 Regulates Granule Cell Pax6 Expression and Cell Proliferation in Early Cerebellar Development. in PLoS ONE 2015
Data show that R-Smad Proteins SMAD1 and SMAD5, which transduce bone morphogenetic protein (BMP) signals, recognize enhancer regions together with Kruppel-like factors KLF4 and KLF5 in naive embryonic stem cell (mESCs).
illustrates that KLF5 may modulate DNA repair pathways to prevent intestinal injury induced by TBI. KLF5 signaling provides a novel field for identification of potential therapeutic targets for the treatment of radiation-induced intestinal damage
Cardiac myocyte KLF5 is a transcriptional regulator of Ppara (show PPARA Antibodies) and cardiac energetics.
In embryonic stem cells, we show that Klf5, but not JunB (show JUNB Antibodies) is a key LIF (show LIF Antibodies) effector of cell plasticity.
the regulatory functions of Klf5 acetylation in ESC self-renewal and differentiation
unravels a novel mechanism how matrix stiffness regulates cellular proliferation and highlights the importance of matrix stiffness-modulated Klf5/Klf4 (show KLF4 Antibodies) in the regulation of renal physiologic functions and fibrosis progression
that estrogen biphasically modulates prostate tumor formation by regulating Kruppel-like zinc finger transcription factor (show OSR1 Antibodies) 5 (show CEBPB Antibodies)-dependent transcription through estrogen receptor beta (show ESR2 Antibodies)
KLF5 loss enhances tumor angiogenesis by attenuating PI3K/AKT (show AKT1 Antibodies) signaling and subsequent accumulation of HIF1alpha (show HIF1A Antibodies) in PTEN (show PTEN Antibodies) deficient prostate tumors.
Simultaneous downregulation of KLF5 and Fli1 (show FLI1 Antibodies) is a key feature underlying systemic sclerosis.
TMEM16A (show ANO1 Antibodies) and myocardin (show MYOCD Antibodies) form a positive feedback loop that is disrupted by KLF5 during Ang II (show AGT Antibodies)-induced vascular remodeling.
demonstrate that a 186bp region is the minimal essential region and that Sp3 (show SP3 Antibodies)-GC1 (show OLFM4 Antibodies) binding is essential to the basal expression of KLF5
We provide the first evidence that the expression of KLF5 is up-regulated in small airways and pulmonary vessels of patients with COPD (show ARCN1 Antibodies) and may be involved in the tissue remodeling of COPD (show ARCN1 Antibodies).
our results indicate that KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA (show VEGFA Antibodies) transcription
Data indicate direct binding of microRNA miR (show MLXIP Antibodies)-375 to the 3'-untranslated region of transcription factor KLF5.
findings collectively suggest that TNFAIP2 (show TNFAIP2 Antibodies) is a direct KLF5 target gene, and both KLF5 and TNFAIP2 (show TNFAIP2 Antibodies) promote breast cancer cell proliferation, migration and invasion through Rac1 and Cdc42 (show CDC42 Antibodies)
ABL (show ABL1 Antibodies)-N administration induced apoptosis of PC3 (show PCSK1 Antibodies) cells in a dose-dependent manner, along with the enhanced activity of caspases and increased Bax (show BAX Antibodies)/Bcl-2 (show BCL2 Antibodies) ratio. Expression of KLF5, Stat5b (show STAT5B Antibodies) and ICAM-1 (show ICAM1 Antibodies) was significantly downregulated in PC3 (show PCSK1 Antibodies) cells.
KLF5/Sox4 regulatory signaling play an important role in lung tumorigenesis, which might represent novel therapeutic targets to manage lung carcinoma.
BAP1 (show RNF2 Antibodies) interacts directly with KLF5 and stabilizes KLF5 via deubiquitination.
Data suggest both KLF5 and FYN (FYN proto-oncogene) are important in regulation of migration in bladder cancer cells; KLF5 up-regulates cell migration, lamellipodia formation, expression of FYN, and phosphorylation of FAK (focal adhesion kinase).
ATXN3L (show ATXN3L Antibodies) has a role in the regulation of KLF5 stability in breast cancer
This gene encodes a member of the Kruppel-like factor subfamily of zinc finger proteins. Since the protein localizes to the nucleus and binds the epidermal growth factor response element, it is thought to be a transcription factor.
Kruppel-like factor 5 (intestinal)
, Krueppel-like factor 5-like
, Kruppel-like factor 5
, basic-transcription-element-binding-protein 2
, basic transcription element binding protein 2
, basic transcription element binding protein BTEB2
, BTE-binding protein 2
, Krueppel-like factor 5
, basic transcription element-binding protein 2
, intestinal-enriched krueppel-like factor
, transcription factor BTEB2
, GC box binding protein 2
, GC-box-binding protein 2
, colon krueppel-like factor
, colon kruppel-like factor
, intestinal-enriched kruppel-like factor